Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1992 Feb;156(2):202–204.

The Papanicolaou smear.

A King 1, K Clay 1, E Felmar 1, D G Heustis 1, R M Karns 1, P Krahl 1, W D Tench 1
PMCID: PMC1003213  PMID: 1311134

Full text

PDF
202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alons-van Kordelaar J. J., Boon M. E. Diagnostic accuracy of squamous cervical lesions studied in spatula-cytobrush smears. Acta Cytol. 1988 Nov-Dec;32(6):801–804. [PubMed] [Google Scholar]
  2. Bearman D. M., MacMillan J. P., Creasman W. T. Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols. Obstet Gynecol. 1987 Feb;69(2):151–155. [PubMed] [Google Scholar]
  3. Berkowitz R. S., Ehrmann R. L., Lavizzo-Mourey R., Knapp R. C. Invasive cervical carcinoma in young women. Gynecol Oncol. 1979 Dec;8(3):311–316. doi: 10.1016/0090-8258(79)90040-4. [DOI] [PubMed] [Google Scholar]
  4. Christopherson W. M., Lundin F. E., Jr, Mendez W. M., Parker J. E. Cervical cancer control: a study of morbidity and mortality trends over a twenty-one-year period. Cancer. 1976 Sep;38(3):1357–1366. doi: 10.1002/1097-0142(197609)38:3<1357::aid-cncr2820380340>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  5. Coppleson L. W., Brown B. Estimation of the screening error rate from the observed detection rates in repeated cercival cytology. Am J Obstet Gynecol. 1974 Aug 1;119(7):953–958. doi: 10.1016/0002-9378(74)90013-1. [DOI] [PubMed] [Google Scholar]
  6. Cramer D. W. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer. 1974 Dec;34(6):2018–2027. doi: 10.1002/1097-0142(197412)34:6<2018::aid-cncr2820340621>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  7. Devesa S. S., Silverman D. T., Young J. L., Jr, Pollack E. S., Brown C. C., Horm J. W., Percy C. L., Myers M. H., McKay F. W., Fraumeni J. F., Jr Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst. 1987 Oct;79(4):701–770. [PubMed] [Google Scholar]
  8. Dickinson L. E. Control of cancer of the uterine cervix by cytologic screening. Gynecol Oncol. 1975 Mar;3(1):1–9. doi: 10.1016/0090-8258(75)90001-3. [DOI] [PubMed] [Google Scholar]
  9. Elias A., Linthorst G., Bekker B., Vooijs P. G. The significance of endocervical cells in the diagnosis of cervical epithelial changes. Acta Cytol. 1983 May-Jun;27(3):225–229. [PubMed] [Google Scholar]
  10. Fletcher A. Screening for cancer of the cervix in elderly women. Lancet. 1990 Jan 13;335(8681):97–99. doi: 10.1016/0140-6736(90)90552-g. [DOI] [PubMed] [Google Scholar]
  11. Frost J. K. Diagnostic accuracy of "cervical smears". Obstet Gynecol Surv. 1969 Jul;24(7 Pt 2):893–908. doi: 10.1097/00006254-196907001-00019. [DOI] [PubMed] [Google Scholar]
  12. Gray L. A. The frequency of taking cervical smears. Obstet Gynecol Surv. 1969 Jul;24(7 Pt 2):909–913. doi: 10.1097/00006254-196907001-00020. [DOI] [PubMed] [Google Scholar]
  13. Gupta J. W., Saito K., Saito A., Fu Y. S., Shah K. V. Human papillomaviruses and the pathogenesis of cervical neoplasia. A study by in situ hybridization. Cancer. 1989 Nov 15;64(10):2104–2110. doi: 10.1002/1097-0142(19891115)64:10<2104::aid-cncr2820641022>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  14. Johannesson G., Geirsson G., Day N. The effect of mass screening in Iceland, 1965-74, on the incidence and mortality of cervical carcinoma. Int J Cancer. 1978 Apr 15;21(4):418–425. doi: 10.1002/ijc.2910210404. [DOI] [PubMed] [Google Scholar]
  15. Koss L. G. Dysplasia. A real concept or a misnomer? Obstet Gynecol. 1978 Mar;51(3):374–379. [PubMed] [Google Scholar]
  16. Koss L. G. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA. 1989 Feb 3;261(5):737–743. [PubMed] [Google Scholar]
  17. Lorincz A. T., Temple G. F., Kurman R. J., Jenson A. B., Lancaster W. D. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst. 1987 Oct;79(4):671–677. [PubMed] [Google Scholar]
  18. Mandelblatt J., Gopaul I., Wistreich M. Gynecological care of elderly women. Another look at Papanicolaou smear testing. JAMA. 1986 Jul 18;256(3):367–371. [PubMed] [Google Scholar]
  19. Martin P. L. How preventable is invasive cervical cancer? A community study of preventable factors. Am J Obstet Gynecol. 1972 Jun 15;113(4):541–548. doi: 10.1016/s0002-9378(15)32505-9. [DOI] [PubMed] [Google Scholar]
  20. Reeves W. C., Brinton L. A., García M., Brenes M. M., Herrero R., Gaitán E., Tenorio F., de Britton R. C., Rawls W. E. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med. 1989 Jun 1;320(22):1437–1441. doi: 10.1056/NEJM198906013202201. [DOI] [PubMed] [Google Scholar]
  21. Reissman S. E. Comparison of two Papanicolaou smear techniques in a family practice setting. J Fam Pract. 1988 May;26(5):525–529. [PubMed] [Google Scholar]
  22. Richart R. M. Current concepts in obstetrics and gynecology: The patient with an abnormal Pap smear--screening techniques and managment. N Engl J Med. 1980 Feb 7;302(6):332–334. doi: 10.1056/NEJM198002073020606. [DOI] [PubMed] [Google Scholar]
  23. Roberts A. D., Denholm R. B., Cordiner J. W. Cervical intraepithelial neoplasia in postmenopausal women with negative cervical cytology. Br Med J (Clin Res Ed) 1985 Jan 26;290(6464):281–281. doi: 10.1136/bmj.290.6464.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rylander E. Negative smears in women developing invasive cervical cancer. Acta Obstet Gynecol Scand. 1977;56(2):115–118. doi: 10.3109/00016347709158352. [DOI] [PubMed] [Google Scholar]
  25. Shulman J. J., Hontz A., Sedlis A., Walters A. T., Balin H., LoScuito L. The Pap smear: take two. Am J Obstet Gynecol. 1975 Apr 15;121(8):1024–1028. doi: 10.1016/s0002-9378(16)33584-0. [DOI] [PubMed] [Google Scholar]
  26. Shy K., Chu J., Mandelson M., Greer B., Figge D. Papanicolaou smear screening interval and risk of cervical cancer. Obstet Gynecol. 1989 Dec;74(6):838–843. [PubMed] [Google Scholar]
  27. Slattery M. L., Robison L. M., Schuman K. L., French T. K., Abbott T. M., Overall J. C., Jr, Gardner J. W. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA. 1989 Mar 17;261(11):1593–1598. [PubMed] [Google Scholar]
  28. Timonen S., Nieminen U., Kauraniemi T. Letter: Cervical screening. Lancet. 1974 Mar 9;1(7854):401–402. doi: 10.1016/s0140-6736(74)93163-8. [DOI] [PubMed] [Google Scholar]
  29. Walker J., Bloss J. D., Liao S. Y., Berman M., Bergen S., Wilczynski S. P. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol. 1989 Nov;74(5):781–785. [PubMed] [Google Scholar]
  30. Walton R. J. Editorial: The task force on cervical cancer screening programs. Can Med Assoc J. 1976 Jun 5;114(11):981–981. [PMC free article] [PubMed] [Google Scholar]
  31. Weintraub N. T., Violi E., Freedman M. L. Cervical cancer screening in women aged 65 and over. J Am Geriatr Soc. 1987 Sep;35(9):870–875. doi: 10.1111/j.1532-5415.1987.tb02340.x. [DOI] [PubMed] [Google Scholar]
  32. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990 Apr 6;248(4951):76–79. doi: 10.1126/science.2157286. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES